Jul 12, 2007 by Brian LawlerNoven's Novel AcquisitionWith JDS Pharmaceuticals, the company is moving toward more traditional oral drugs.
Jul 11, 2007 by Brian LawlerNot All Pharmaceutical Markets Are the SameThe case of China's former FDA leader highlights the issues facing the country's pharmaceutical industry.
Jul 11, 2007 by Brian LawlerWhy Depomed Shares Were DumpedIn a recent trial, a pain medication wasn't as effective as had been hoped.
Jul 10, 2007 by Brian LawlerDon't Mess With the Pfizer Mini-Tender OfferPfizer investors get an offer they can refuse.
Jul 6, 2007 by Brian LawlerAnother Round for Alkermes' Alcohol FightAlkermes advances the development of another drug.
Jul 6, 2007 by Brian LawlerMedicines Decides Not To ShareThe Medicines Company reacquires its own drug.
Jul 3, 2007 by Brian Lawler"Sicko" Is Thought-Provoking, But ...A review of Michael Moore's latest film, "Sicko."
Jun 29, 2007 by Brian LawlerGenentech's All GoodThe biotech's latest partnership deal is nothing to worry about.
Jun 28, 2007 by Brian LawlerMomentous Delay for Momenta?Momenta announces a delay in the FDA review of its lead drug.
Jun 27, 2007 by Brian LawlerWaiting on GPCGPC's marketing partner files a European marketing application for its top drug.
Jun 26, 2007 by Brian LawlerChanging of the Guard at EncysiveEncysive restructures to reduce its cash burn.
Jun 25, 2007 by Brian LawlerNeurochem Hems and HawsNeurochem delays the announcement of clinical trial results.
Jun 22, 2007 by Brian LawlerNovartis' Good WeekNovartis receives a pair of positive regulatory decisions.
Jun 21, 2007 by Brian LawlerOnyx on the ClockOnyx's partner files a marketing application to expand the use of its lead drug.
Jun 21, 2007 by Brian LawlerPanacos Validates ItselfPanacos releases more clinical trial results for an exciting drug.
Jun 21, 2007 by Brian LawlerPfizer Gets Held UpThe FDA issues an approvable letter for its novel HIV compound.
Jun 20, 2007 by Brian LawlerGPC Markets ItselfGPC showcases itself at two investor conferences last week.
